Machine learning-based diagnosis and risk factor analysis of cardiocerebrovascular disease based on KNHANES

Taeseob Oh1, Dongkyun Kim2, Siryeol Lee3

  • 1Department of Family Medicine, Kyung Hee University Hospital, Seoul, Republic of Korea.

Scientific Reports
|February 11, 2022
PubMed

Insights

Machine learning models accurately predict cardiocerebrovascular disease (CVD) risk. Key factors include age, sex, and hypertension, enabling better public health screening.

Area of Science:

  • Computational epidemiology
  • Machine learning in healthcare
  • Public health surveillance

Background:

  • Cardiocerebrovascular disease (CVD) prevalence is rising globally, posing a significant public health challenge.
  • Accurate and interpretable screening methods are crucial for early detection and prevention of CVD.
  • Existing screening methods face limitations in scalability and precision for large populations.

Purpose of the Study:

  • To develop and evaluate machine learning classifiers for predicting CVD risk.
  • To identify key risk factors contributing to CVD prevalence using interpretable AI.
  • To enhance the accuracy and interpretability of CVD screening tools.

Main Methods:

  • Utilized Korea National Health and Nutrition Examination Survey (KNHANES) data.
  • Applied advanced machine learning algorithms: multi-layer perceptron, support vector machine, random forest, and light gradient boosting.
  • Employed data rebalancing techniques (SMOTE, random undersampling) and feature selection (VIF, Boruta) for improved model performance and interpretability.

Main Results:

  • Achieved excellent classifier performance with Area Under the Curve (AUC) values exceeding 0.853.
  • Identified age, sex, and hypertension as the most significant risk factors for CVD.
  • Revealed positive correlations between CVD and age, hypertension, and BMI; negative correlations with female sex, alcohol consumption, and higher income.

Conclusions:

  • Machine learning models offer a highly accurate approach to CVD risk prediction.
  • Feature selection and class balancing techniques significantly enhance model interpretability.
  • The findings provide valuable insights for targeted public health interventions and CVD prevention strategies.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
216
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
247
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
383
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
78
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.5K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
106